Perseus-Soros BioPharmaceutical Fund, L.P.
Investment Details
Investor Type
Private Equity
Asset Class Focus
Private Equity, Venture Capital
Stage Focus
Seed, Early Stage, Series A, Series B, Growth, Late Stage, Pre-IPO, Buyout, Turnaround, Distressed
Geographical Focus
United States
Industries Focus
- Healthcare
- Life Sciences
- Pharmaceuticals
- Medical Devices
- Diagnostics
- Biotechnology
- Medical Research
- Clinical Trials
- Oncology
- Medical Equipment
- Immunology
- Genomics
- Proteomics
- Biopharmaceuticals
- Drug Development
Investment Size:
5,000,000 to 50,000,000 USD
Investor Details Founded: 2001
Perseus-Soros BioPharmaceutical Fund, L.P. is a private equity firm specializing in investments within the biopharmaceutical sector. The firm focuses on both private and public life science companies, aiming to support the development and commercialization of innovative medical treatments and technologies. Their investment approach encompasses a wide range of stages, from seed funding to buyouts, reflecting a flexible strategy tailored to the unique needs of each opportunity.
The fund's portfolio includes a diverse array of companies across various industries, such as biotechnology, healthcare, medical equipment, pharmaceuticals, and medical devices. This broad industry focus enables the firm to leverage its expertise in the life sciences to identify and nurture promising ventures. Geographically, the fund primarily concentrates on opportunities within the United States, aligning with its strategic objectives and operational capabilities.
Over the years, Perseus-Soros BioPharmaceutical Fund has demonstrated a commitment to fostering growth and innovation in the biopharmaceutical sector. Their investment philosophy emphasizes active involvement in portfolio companies, aiming to drive value creation through strategic guidance and support. This approach has led to a track record of successful investments and exits, underscoring the firm's role as a significant player in the biopharmaceutical investment landscape.
Requirements
- Strong management team
- Innovative product pipeline
- Scalable business model
- Clear regulatory pathway
- Potential for significant market impact
- Alignment with fund's investment strategy
- Ability to achieve liquidity within a reasonable timeframe
- Competitive market positioning
- Demonstrated clinical or commercial validation
- Robust intellectual property portfolio
Contact
[Official Website Hidden]
[HQ Location Hidden]
Portfolio Companies
- Ambit Biosciences
- CeNeRx BioPharma
- ViroPharma Inc.
- Xanodyne Pharmaceuticals
- SkinMedica
- Advion Inc.
- Cardiokine
- MAP Pharmaceuticals
- Valentis Inc.
- Auxilium Pharmaceuticals Inc.
- Barrier Therapeutics Inc.
- Adams Respiratory Therapeutics Inc.
- Bioenvision Inc.
- CeNeRx BioPharma Inc.
Claim this Investor
Are you an official representative of Perseus-Soros BioPharmaceutical Fund, L.P.?
Claim this investor to update information, manage your profile, and get a verified seal.
Claim